The medicinal cannabis sectors in Australia and New Zealand are entering a more mature, data-driven phase marked by rising THC use, evolving patient access models, and closer regulatory scrutiny, fresh data from Prohibition Partners has revealed.

The Australia & New Zealand Cannabis Data Pack – produced in collaboration with Cannabiz – outlined how both markets have expanded rapidly since legalisation, while taking different paths toward stability and oversight.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Avatar photo

Adam Sheldon

Adam is a digital journalist at Cannabiz. He previously worked at the ABC covering news and current affairs for the public service broadcaster and breaking national news across Australia. He cut his...

Leave a comment